Table 2 Crude blood pressure values and hypertension prevalence according to genotypes in MDC-CVA
RNLS | RNLS | RNLS | RNLS | RNLS | |
|---|---|---|---|---|---|
rs2576178 AA | rs2576178 AG | rs2576178 GG | rs2576178 A-carriers | rs2576178 G-carriers | |
n = 3,035 | n = 2,183 | n = 448 | n = 5,218 | n = 2,631 | |
SBP, mmHg | 141.63±18.96 | 140.42±18.91 | 141.77±18.89 | 141.12±18.95 | 140.65±18.91 |
DBP, mmHg | 87.01±9.49 | 86.75±9.39 | 87.38±9.28 | 86.89±9.45 | 87.01±9.49 |
Hypertension, % | 63.8 | 62.8 | 63.4 | 63.4 | 62.9 |
Antihypertensive treatment, % | 16.0 | 16.8 | 15.8 | 16.3 | 16.6 |
RNLS | RNLS | RNLS | RNLS | RNLS | |
rs2296545 CC | rs2296545 CG | rs2296545 GG | rs2296545 C-carriers | rs2296545 G-carriers | |
n = 1,663 | n = 2,768 | n = 1,177 | n = 4431 | n = 3,945 | |
SBP, mmHg | 141.33±18.79 | 141.08±18.82 | 141.58±19.53 | 141.17±18.81 | 141.23±19.04 |
DBP, mmHg | 87.08±9.32 | 86.94±9.41 | 86.95±9.62 | 86.99±9.38 | 86.95±9.47 |
Hypertension, % | 63.5 | 63.5 | 63.2 | 63.5 | 63.4 |
Antihypertensive treatment, % | 17.4 | 15.9 | 15.9 | 16.5 | 15.9 |